Design and Evaluation of Transdermal Drug Delivery System for Curcumin as an Anti-Inflammatory Drug

REFERENCES

• R. J. Anto, G. Kuttan, K. V. D. Babu, K. N. Rajasekharan, and R. Kuttan. (1998). Antiinflammatory activity of natural and synthetic curcuminoids. Pharm. Pharmacol. Commun. 4:103–106.
   Web of Science ®Google Scholar
• P. Arora, and P. Mukherjee. (2002). Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 91:2076–2089.
   PubMed Web of Science ®Google Scholar
• A. Asai, and T. Miyazawa. (2000). Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. 67:2785–2793.
   PubMed Web of Science ®Google Scholar
• A. D. Bangham, M. W. Hill, and N. G. A. Miller. (1974). Preparation and use of liposomes as models of biological membranes. In E. D. Korn (Ed.), Methods in membrane biology (Vol. 1, Chapter 1, pp. 1–64). New York: Plenum Press.
   Google Scholar
• A. L. Cheng, J. K. Lin, M. M. Hsu, J. T. Lin, M. M. Hsu, Y. F. Ho, T. S. Shen, J. Y. Ko, J. T. Lin, B. R. Lin, M. S. Wu, H. S. Yu, S. H. Jee, G. S. Chen, T. M. Chen, C. A. Chen, M. K. Lai, Y. S. Pu, M. H. Pan, U. J. Wang, C. C. Tsai, and C. Y. Hsieh. (2001). Phase I chemoprevention clinical trial of curcumin, a chemopreventive agent, in patients with high risk or pre-malignant lesions. Anticancer Res. 21:2895–2900.
   PubMed Web of Science ®Google Scholar
• S. C. Chi, E. S. Park, and H. Kim. (1995). Effect of penetration enhancers on flurbiprofen permeation though rat skin. Int. J. Pharm. 126:267–274.
   Web of Science ®Google Scholar
• Y. W. Chien. (1987). Transdermal therapeutic system. In J. R. Robinson, and V. H. L. Lee. (Eds.), Controlled drug delivery fundamentals and applications (2nd ed., pp. 524–552). New York: Marcel Dekker, Inc.
   Google Scholar
• E. R. Cooper. (1984). Increased skin permeability for lipophilic molecules. Pharm. Sci., 73:1153–1156.
   PubMed Web of Science ®Google Scholar
• J. H. Draize, G. Woodward, and H. O. Calvery. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exp. Ther. 82:377–379.
   Web of Science ®Google Scholar
• M. Goodman, and B. W. Barry. (1988). Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91:323–327.
   PubMed Web of Science ®Google Scholar
• M. Goodman, and B. W. Barry. (1989). Lipid-protein-partitioning (LPP) theory of skin enhancer activity: Finite dose technique. Int. J. Pharm. 57:29–40.
   Web of Science ®Google Scholar
• R. Gupta, and B. Mukherjee. (2003). Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethyl cellulose matrices. Drug Dev. Ind. Pharm. 29:1–7.
   PubMed Web of Science ®Google Scholar
• J. M. Harris, and P. S. J. Spencer. (1962). A modified plythesmographic apparatus for recording volume changes in rat paw. J. Pharm. Pharmacol. 14:464–466.
   PubMed Web of Science ®Google Scholar
• J. H. Hu, and Y. Zhu. (1996). Effect of enhancers on the permeation of ketoprofen in-vitro. Yao-Hsueh-Hsueh-Pao, 31:48–53.
   Google Scholar
• M. T. Huang, R. C. Smart, C. Q. Wong, and A. H. Conney. (1988). Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 48 (21):5941–5946.
   PubMed Web of Science ®Google Scholar
• S. Katayose, and K. Kataoka. (1997). Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug. Chem. 8:702–707.
   PubMed Web of Science ®Google Scholar
• A. D. Keith. (1983). Polymer matrix consideration for transdermal devices. Drug Dev. Ind. Pharm. 9:605–621.
   Web of Science ®Google Scholar
• D. D. Kim, and Y. W. Chien. (1996). Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation. J. Pharm. Sci. 85:214–219.
   PubMed Web of Science ®Google Scholar
• V. Kumar, S. A. Lewis, S. Mutalik, D. B. Shenoy, M. Venkatesh, and N. Udupa. (2002). Biodegradable microspheres of curcumin for treatment of inflammation. Indian J. Physiol. Pharmacol. 46 (2):209–217.
   PubMedGoogle Scholar
• D. V. Kusum, S. Saisivam, G. R. Maria, and P. U. Deepti. (2003). Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev. Ind. Pharm. 29:495–503.
   PubMed Web of Science ®Google Scholar
• E. Limpongsa, and K. Umprayn. (2008). Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system. AAPS PharmSciTech. 9 (2):464–470.
   PubMed Web of Science ®Google Scholar
• A. N. Misra. (1997). Controlled and novel drug delivery. InN. K. Jain (Ed.), Transdermal drug delivery ( pp. 100–101). New Delhi, India: CBS Publisher and Distributor.
   Google Scholar
• S. Mutalik, and N. Udupa. (2004). Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J. Pharm. Sci. 93:1577–1594.
   PubMed Web of Science ®Google Scholar
• A. Namdeo, and N. K. Jain. (2002). Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride. J. Control. Release, 82:223–236.
   PubMed Web of Science ®Google Scholar
• P. R. Rao, and P. V. Diwan. (1998). Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev. Ind. Pharm. 24:327–336.
   PubMed Web of Science ®Google Scholar
• D. S. Rao, N. C. Sekhara, M. N. Satyanarayana, and M. Srinivasan. (1970). Effect of curcumin on serum and liver cholesterol levels in the rat. J. Nutr., 100 (11):1307–1315.
   PubMed Web of Science ®Google Scholar
• V. Ravindranath, and N. Chandrasekhara. (1980). Absorption and tissue distribution of curcumin in rats. Toxicology, 16:259–265.
   PubMed Web of Science ®Google Scholar
• P. L. Ritger, and N. A. Peppas. (1987). A simple equation for description of solute release, I: Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release, 5:23–26.
   Google Scholar
• P. Sakellariou, R. C. Rowe, and E. F. T. White. (1986). An evaluation of the interaction and plasticizing efficiency of the polyethylene glycols in ethyl cellulose and hydroxypropyl methylcellulose films using the torsional braid pendulum. Int. J. Pharm. 31:55–64.
   Web of Science ®Google Scholar
• M. N. Sreejayan Rao. (1994). Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46 (12):1013–1016.
   PubMed Web of Science ®Google Scholar
• R. C. Srimol, and B. N. Dhawan. (1973). Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25:447–452.
   PubMedGoogle Scholar
• W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang. (2007). Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337 (1–2):299–306.
   PubMed Web of Science ®Google Scholar
• K. Vidyalakshmi, K. N. Rashmi, T. M. Pramodkumar, and K. Siddaramaiah. (2004). Studies on formulation and in vitro evaluation of PVA/chitosan blend films for drug delivery. J. Macromol. Sci. Pure Appl. Chem. 41 (10):1115–1122.
   Web of Science ®Google Scholar
• A. Wade, and P. J. Weller. (1994). Handbook of pharmaceutical excipients ( pp. 362–366). Washington, DC: American Pharmaceutical Publishing Association.
   Google Scholar
• X. Wang, Y. Jiang, Y.-W. Wang, M.-T. Huang, C.-T. Ho, and Q. Huang. (2008). Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 108 (2):419–424.
   PubMed Web of Science ®Google Scholar
• C. A. Winter, E. A. Risley, and G. W. Nuss. (1962). Carrageenan induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:544–547.
   PubMed Web of Science ®Google Scholar